{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+-+Healthy+Participants&page=3", "query": { "intervention": "Placebo - Healthy Participants", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 2391, "total_pages": 240, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+-+Healthy+Participants&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+-+Healthy+Participants&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T01:32:25.954Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00659191", "title": "A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infection" ], "interventions": [ { "name": "GSK1265744", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 58, "start_date": "2008-02", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2010-10-15", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 5, "location_summary": "Fort Lauderdale, Florida • Orlando, Florida • Charlotte, North Carolina + 1 more", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659191" }, { "nct_id": "NCT05756920", "title": "This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "ABL301", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ABL Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 91, "start_date": "2022-12-31", "completion_date": "2025-04-30", "has_results": false, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05756920" }, { "nct_id": "NCT00925574", "title": "A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "CNTO 1959; Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 71, "start_date": "2009-06-04", "completion_date": "2010-10-11", "has_results": false, "last_update_posted_date": "2017-09-05", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 8, "location_summary": "Los Angeles, California • San Diego, California • Miramar, Florida + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miramar", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00925574" }, { "nct_id": "NCT04480333", "title": "Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Covid19", "Corona Virus Infection", "Severe Acute Respiratory Syndrome", "Severe Acute Respiratory Infection", "Severe Acute Respiratory Syndrome (SARS) Pneumonia", "Severe Acute Respiratory Syndrome of Upper Respiratory Tract", "Neurodegeneration", "Neuroinflammatory Response" ], "interventions": [ { "name": "Drug: NA-831 - 0.10 mg/kg", "type": "DRUG" }, { "name": "Placebo- 0.10 mg/kg", "type": "DRUG" }, { "name": "Drug: NA-831 - 0.20 mg/kg", "type": "DRUG" }, { "name": "Placebo- 0.20 mg/kg", "type": "DRUG" }, { "name": "Drug: GS-5734 - 1.00 mg/kg", "type": "DRUG" }, { "name": "Placebo- 1.00 mg/kg", "type": "DRUG" }, { "name": "Drug: GS-5734 - 2.00 mg/kg", "type": "DRUG" }, { "name": "Placebo- 2.00 mg/kg", "type": "DRUG" }, { "name": "Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo 0.10 mg + 1.00 mg/kg", "type": "COMBINATION_PRODUCT" }, { "name": "Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo 0.20 mg + 2.00 mg/kg", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Biomed Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "21 Years to 50 Years" }, "enrollment_count": 45, "start_date": "2020-09-15", "completion_date": "2021-03-31", "has_results": false, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "Sunnyvale, California", "locations": [ { "city": "Sunnyvale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04480333" }, { "nct_id": "NCT07676435", "title": "Ongoing Lung Decline With Age Intensified Response", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Age-Related Lung Function Decline" ], "interventions": [ { "name": "Fisetin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 40, "start_date": "2026-06-17", "completion_date": "2027-07-15", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07676435" }, { "nct_id": "NCT00555035", "title": "GSK1349572 First Time in Human Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "GSK1349572", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 20, "start_date": "2007-11", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2010-10-15", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00555035" }, { "nct_id": "NCT02504476", "title": "Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia or Schizoaffective Disorder" ], "interventions": [ { "name": "AMG 581", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 52, "start_date": "2015-08", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2016-03-07", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 2, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02504476" }, { "nct_id": "NCT03224793", "title": "Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "BIIB059", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2017-10-04", "completion_date": "2018-06-12", "has_results": false, "last_update_posted_date": "2018-08-31", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03224793" }, { "nct_id": "NCT01334242", "title": "A Study to Determine the Pharmacodynamics of LX4211 Relative to Meals in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Schedule A", "type": "DRUG" }, { "name": "Schedule B", "type": "DRUG" }, { "name": "Schedule C", "type": "DRUG" }, { "name": "Schedule D", "type": "DRUG" }, { "name": "Schedule E", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lexicon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 14, "start_date": "2011-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2011-05-19", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01334242" }, { "nct_id": "NCT07808073", "title": "A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity", "Overweight" ], "interventions": [ { "name": "LY4329090", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 184, "start_date": "2026-09", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-07T01:32:25.954Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Dallas, Texas", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07808073" } ] }